Takanori Hirose Selected Research

Takanori Hirose Research Topics

Disease

51	Neoplasms (Cancer) 01/2024 - 10/2002
9	Glioma (Gliomas) 01/2023 - 01/2002
6	Sarcoma (Soft Tissue Sarcoma) 01/2022 - 01/2002
4	Neoplasm Metastasis (Metastasis) 04/2021 - 08/2003
4	Ependymoma 01/2021 - 01/2007
4	Astrocytoma (Pilocytic Astrocytoma) 01/2021 - 05/2006
4	Glioblastoma (Glioblastoma Multiforme) 11/2020 - 05/2006
3	Neurofibroma 01/2023 - 04/2003
3	Meningioma (Meningiomas) 01/2022 - 01/2005
3	Neuroepithelial Neoplasms (Gliomatosis Cerebri) 10/2021 - 08/2008
3	Lymphoma (Lymphomas) 01/2020 - 05/2005
3	Carcinoma (Carcinomatosis) 11/2019 - 08/2005
3	Hemangioblastoma 04/2015 - 01/2005
3	Liposarcoma 08/2011 - 09/2006
2	Ewing Sarcoma (Sarcoma, Ewing) 10/2021 - 04/2021
2	Oligodendroglioma 10/2013 - 03/2012
2	Hyperplasia 04/2008 - 05/2005
2	Chordoma 07/2005 - 02/2004
2	Nerve Sheath Neoplasms (Nerve Sheath Neoplasm) 08/2003 - 04/2003
1	Hematologic Neoplasms (Hematological Malignancy) 05/2023
1	Osteosclerosis 05/2023
1	Angiofibroma 01/2023
1	Solitary Fibrous Tumors 01/2023
1	Soft Tissue Neoplasms 01/2022
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 04/2021
1	Colonic Neoplasms (Colon Cancer) 03/2021
1	Synovial Sarcoma (Synovioma) 03/2021
1	Clear Cell Sarcoma 12/2020
1	Thrombosis (Thrombus) 11/2019
1	Hemangiosarcoma (Angiosarcoma) 11/2019
1	Tuberous Sclerosis (Bourneville's Disease) 01/2019
1	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 01/2019
1	Hepatocellular Carcinoma (Hepatoma) 05/2016

Drug/Important Bio-Agent (IBA)

10	S100 Proteins (S 100 Protein)IBA 12/2020 - 04/2002
9	Proteins (Proteins, Gene)FDA Link 01/2024 - 04/2003
7	Keratins (Keratin)IBA 12/2020 - 04/2003
6	Glial Fibrillary Acidic ProteinIBA 04/2015 - 04/2002
5	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2023 - 03/2012
5	DesminIBA 12/2020 - 08/2003
5	SynaptophysinIBA 12/2020 - 04/2002
5	VimentinIBA 12/2020 - 08/2003
4	Mucin-1 (CA 15-3 Antigen)IBA 04/2015 - 04/2003
3	DNA (Deoxyribonucleic Acid)IBA 05/2022 - 03/2012
3	CAM 5.2 antigenIBA 01/2021 - 02/2005
3	CytokinesIBA 11/2020 - 09/2015
3	Interleukin-10 (Interleukin 10)IBA 01/2020 - 09/2015
3	Interleukin-6 (Interleukin 6)IBA 10/2019 - 08/2011
3	AntibodiesIBA 04/2019 - 01/2005
3	CollagenIBA 10/2012 - 08/2003
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 08/2011 - 10/2004
3	Cyclin-Dependent Kinase 4IBA 10/2006 - 01/2002
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2020
2	GadoliniumIBA 10/2021 - 08/2008
2	ChemokinesIBA 11/2020 - 01/2020
2	Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA 04/2019 - 01/2018
2	Carcinoembryonic AntigenIBA 03/2016 - 03/2011
2	Neurofilament ProteinsIBA 08/2010 - 04/2002
2	Cisplatin (Platino)FDA LinkGeneric 01/2010 - 10/2004
2	Prion ProteinsIBA 10/2007 - 10/2002
2	ErbB Receptors (EGF Receptor)IBA 02/2007 - 01/2002
2	LipidsIBA 07/2005 - 10/2002
2	Bromocriptine (Parlodel)FDA LinkGeneric 07/2005 - 04/2005
2	Cadherins (E-Cadherin)IBA 01/2005 - 02/2004
2	beta CateninIBA 01/2005 - 02/2004
2	Cell Adhesion MoleculesIBA 01/2005 - 02/2004
1	OsteoprotegerinIBA 05/2023
1	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 01/2023
1	alpha-hydroxyglutarateIBA 01/2023
1	Essential Amino AcidsIBA 01/2022
1	Phenylalanine (L-Phenylalanine)FDA Link 01/2022
1	Amino Acid Transport Systems (Amino Acid Transporter)IBA 01/2022
1	5'-methylthioadenosine phosphorylase (methylthioadenosine nucleosidase)IBA 01/2022
1	RNA-Binding Protein EWSIBA 10/2021
1	Inhibins (Inhibin)IBA 12/2020
1	Muramidase (Lysozyme)IBA 11/2020
1	VemurafenibIBA 11/2020
1	4- (2- (2- hydroxycyclohexylamino)benzothiazol- 6- yloxy)pyridine- 2- carboxylic acid methylamideIBA 11/2020
1	Histocompatibility Antigens Class IIIBA 11/2020
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2020
1	LigandsIBA 01/2020
1	succinyl- interleukin-2IBA 01/2020
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 11/2019
1	NF-kappa B (NF-kB)IBA 04/2019
1	lipoarabinomannan (LAM)IBA 01/2019
1	RNA (Ribonucleic Acid)IBA 12/2018
1	Monomeric GTP-Binding ProteinsIBA 01/2018
1	Collagen Type III (Type III Collagen)IBA 01/2018
1	Neurofibromin 1 (Neurofibromin)IBA 01/2018
1	SOXB1 Transcription FactorsIBA 01/2018
1	tranilastIBA 01/2018
1	MART-1 AntigenIBA 01/2017
1	multidrug resistance protein 3IBA 05/2016
1	Member 11 Subfamily B ATP Binding Cassette TransporterIBA 05/2016

Therapy/Procedure

11	Therapeutics 01/2022 - 01/2002
7	Drug Therapy (Chemotherapy) 01/2022 - 11/2006
4	Radiotherapy 11/2015 - 11/2005
2	Boron Neutron Capture Therapy 01/2022 - 12/2020
1	Laminectomy 10/2021
1	Pneumonectomy (Lung Volume Reduction) 03/2021
1	Hepatectomy 03/2021